This page is part of the FHIR Specification (v1.0.2: DSTU 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
This value set (http://hl7.org/fhir/ValueSet/v3-ObservationType) is defined as part of HL7 v3. Related FHIR content: ObservationType.
Summary
Defining URL: | http://hl7.org/fhir/ValueSet/v3-ObservationType |
Name: | ObservationType |
Definition: | Identifies the kinds of observations that can be performed |
OID: | 2.16.840.1.113883.1.11.16226 (for OID based terminology systems) |
Source Resource | XML / JSON |
This value set is not currently used
This value set includes codes from the following code systems:
This expansion generated 24 Oct 2015
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
Code | System | Display |
_ObservationType | http://hl7.org/fhir/v3/ActCode | ObservationType |
_ActSpecObsCode | http://hl7.org/fhir/v3/ActCode | ActSpecObsCode |
ARTBLD | http://hl7.org/fhir/v3/ActCode | ActSpecObsArtBldCode |
DILUTION | http://hl7.org/fhir/v3/ActCode | ActSpecObsDilutionCode |
AUTO-HIGH | http://hl7.org/fhir/v3/ActCode | Auto-High Dilution |
AUTO-LOW | http://hl7.org/fhir/v3/ActCode | Auto-Low Dilution |
PRE | http://hl7.org/fhir/v3/ActCode | Pre-Dilution |
RERUN | http://hl7.org/fhir/v3/ActCode | Rerun Dilution |
EVNFCTS | http://hl7.org/fhir/v3/ActCode | ActSpecObsEvntfctsCode |
INTFR | http://hl7.org/fhir/v3/ActCode | ActSpecObsInterferenceCode |
FIBRIN | http://hl7.org/fhir/v3/ActCode | Fibrin |
HEMOLYSIS | http://hl7.org/fhir/v3/ActCode | Hemolysis |
ICTERUS | http://hl7.org/fhir/v3/ActCode | Icterus |
LIPEMIA | http://hl7.org/fhir/v3/ActCode | Lipemia |
VOLUME | http://hl7.org/fhir/v3/ActCode | ActSpecObsVolumeCode |
AVAILABLE | http://hl7.org/fhir/v3/ActCode | Available Volume |
CONSUMPTION | http://hl7.org/fhir/v3/ActCode | Consumption Volume |
CURRENT | http://hl7.org/fhir/v3/ActCode | Current Volume |
INITIAL | http://hl7.org/fhir/v3/ActCode | Initial Volume |
_AnnotationType | http://hl7.org/fhir/v3/ActCode | AnnotationType |
_ActPatientAnnotationType | http://hl7.org/fhir/v3/ActCode | ActPatientAnnotationType |
ANNDI | http://hl7.org/fhir/v3/ActCode | diagnostic image note |
ANNGEN | http://hl7.org/fhir/v3/ActCode | general note |
ANNIMM | http://hl7.org/fhir/v3/ActCode | immunization note |
ANNLAB | http://hl7.org/fhir/v3/ActCode | laboratory note |
ANNMED | http://hl7.org/fhir/v3/ActCode | medication note |
_GeneticObservationType | http://hl7.org/fhir/v3/ActCode | GeneticObservationType |
GENE | http://hl7.org/fhir/v3/ActCode | gene |
_ImmunizationObservationType | http://hl7.org/fhir/v3/ActCode | ImmunizationObservationType |
OBSANTC | http://hl7.org/fhir/v3/ActCode | antigen count |
OBSANTV | http://hl7.org/fhir/v3/ActCode | antigen validity |
_IndividualCaseSafetyReportType | http://hl7.org/fhir/v3/ActCode | Individual Case Safety Report Type |
PAT_ADV_EVNT | http://hl7.org/fhir/v3/ActCode | patient adverse event |
VAC_PROBLEM | http://hl7.org/fhir/v3/ActCode | vaccine product problem |
_LOINCObservationActContextAgeType | http://hl7.org/fhir/v3/ActCode | LOINCObservationActContextAgeType |
21611-9 | http://hl7.org/fhir/v3/ActCode | age patient qn est |
21612-7 | http://hl7.org/fhir/v3/ActCode | age patient qn reported |
29553-5 | http://hl7.org/fhir/v3/ActCode | age patient qn calc |
30525-0 | http://hl7.org/fhir/v3/ActCode | age patient qn definition |
30972-4 | http://hl7.org/fhir/v3/ActCode | age at onset of adverse event |
_MedicationObservationType | http://hl7.org/fhir/v3/ActCode | MedicationObservationType |
REP_HALF_LIFE | http://hl7.org/fhir/v3/ActCode | representative half-life |
SPLCOATING | http://hl7.org/fhir/v3/ActCode | coating |
SPLCOLOR | http://hl7.org/fhir/v3/ActCode | color |
SPLIMAGE | http://hl7.org/fhir/v3/ActCode | image |
SPLIMPRINT | http://hl7.org/fhir/v3/ActCode | imprint |
SPLSCORING | http://hl7.org/fhir/v3/ActCode | scoring |
SPLSHAPE | http://hl7.org/fhir/v3/ActCode | shape |
SPLSIZE | http://hl7.org/fhir/v3/ActCode | size |
SPLSYMBOL | http://hl7.org/fhir/v3/ActCode | symbol |
_ObservationIssueTriggerCodedObservationType | http://hl7.org/fhir/v3/ActCode | ObservationIssueTriggerCodedObservationType |
_CaseTransmissionMode | http://hl7.org/fhir/v3/ActCode | case transmission mode |
AIRTRNS | http://hl7.org/fhir/v3/ActCode | airborne transmission |
ANANTRNS | http://hl7.org/fhir/v3/ActCode | animal to animal transmission |
ANHUMTRNS | http://hl7.org/fhir/v3/ActCode | animal to human transmission |
BDYFLDTRNS | http://hl7.org/fhir/v3/ActCode | body fluid contact transmission |
BLDTRNS | http://hl7.org/fhir/v3/ActCode | blood borne transmission |
DERMTRNS | http://hl7.org/fhir/v3/ActCode | transdermal transmission |
ENVTRNS | http://hl7.org/fhir/v3/ActCode | environmental exposure transmission |
FECTRNS | http://hl7.org/fhir/v3/ActCode | fecal-oral transmission |
FOMTRNS | http://hl7.org/fhir/v3/ActCode | fomite transmission |
FOODTRNS | http://hl7.org/fhir/v3/ActCode | food-borne transmission |
HUMHUMTRNS | http://hl7.org/fhir/v3/ActCode | human to human transmission |
INDTRNS | http://hl7.org/fhir/v3/ActCode | indeterminate disease transmission mode |
LACTTRNS | http://hl7.org/fhir/v3/ActCode | lactation transmission |
NOSTRNS | http://hl7.org/fhir/v3/ActCode | nosocomial transmission |
PARTRNS | http://hl7.org/fhir/v3/ActCode | parenteral transmission |
PLACTRNS | http://hl7.org/fhir/v3/ActCode | transplacental transmission |
SEXTRNS | http://hl7.org/fhir/v3/ActCode | sexual transmission |
TRNSFTRNS | http://hl7.org/fhir/v3/ActCode | transfusion transmission |
VECTRNS | http://hl7.org/fhir/v3/ActCode | vector-borne transmission |
WATTRNS | http://hl7.org/fhir/v3/ActCode | water-borne transmission |
_ObservationQualityMeasureAttribute | http://hl7.org/fhir/v3/ActCode | ObservationQualityMeasureAttribute |
AGGREGATE | http://hl7.org/fhir/v3/ActCode | aggregate measure observation |
COPY | http://hl7.org/fhir/v3/ActCode | copyright |
CRS | http://hl7.org/fhir/v3/ActCode | clinical recommendation statement |
DEF | http://hl7.org/fhir/v3/ActCode | definition |
DISC | http://hl7.org/fhir/v3/ActCode | disclaimer |
FINALDT | http://hl7.org/fhir/v3/ActCode | finalized date/time |
GUIDE | http://hl7.org/fhir/v3/ActCode | guidance |
IDUR | http://hl7.org/fhir/v3/ActCode | improvement notation |
ITMCNT | http://hl7.org/fhir/v3/ActCode | items counted |
KEY | http://hl7.org/fhir/v3/ActCode | keyword |
MEDT | http://hl7.org/fhir/v3/ActCode | measurement end date |
MSD | http://hl7.org/fhir/v3/ActCode | measurement start date |
MSRADJ | http://hl7.org/fhir/v3/ActCode | risk adjustment |
MSRAGG | http://hl7.org/fhir/v3/ActCode | rate aggregation |
MSRIMPROV | http://hl7.org/fhir/v3/ActCode | health quality measure improvement notation |
MSRJUR | http://hl7.org/fhir/v3/ActCode | jurisdiction |
MSRRPTR | http://hl7.org/fhir/v3/ActCode | reporter type |
MSRRPTTIME | http://hl7.org/fhir/v3/ActCode | timeframe for reporting |
MSRSCORE | http://hl7.org/fhir/v3/ActCode | measure scoring |
MSRSET | http://hl7.org/fhir/v3/ActCode | health quality measure care setting |
MSRTOPIC | http://hl7.org/fhir/v3/ActCode | health quality measure topic type |
MSRTP | http://hl7.org/fhir/v3/ActCode | measurement period |
MSRTYPE | http://hl7.org/fhir/v3/ActCode | measure type |
RAT | http://hl7.org/fhir/v3/ActCode | rationale |
REF | http://hl7.org/fhir/v3/ActCode | reference |
SDE | http://hl7.org/fhir/v3/ActCode | supplemental data elements |
STRAT | http://hl7.org/fhir/v3/ActCode | stratification |
TRANF | http://hl7.org/fhir/v3/ActCode | transmission format |
USE | http://hl7.org/fhir/v3/ActCode | notice of use |
_ObservationSequenceType | http://hl7.org/fhir/v3/ActCode | ObservationSequenceType |
TIME_ABSOLUTE | http://hl7.org/fhir/v3/ActCode | absolute time sequence |
TIME_RELATIVE | http://hl7.org/fhir/v3/ActCode | relative time sequence |
_ObservationSeriesType | http://hl7.org/fhir/v3/ActCode | ObservationSeriesType |
_ECGObservationSeriesType | http://hl7.org/fhir/v3/ActCode | ECGObservationSeriesType |
REPRESENTATIVE_BEAT | http://hl7.org/fhir/v3/ActCode | ECG representative beat waveforms |
RHYTHM | http://hl7.org/fhir/v3/ActCode | ECG rhythm waveforms |
_PatientImmunizationRelatedObservationType | http://hl7.org/fhir/v3/ActCode | PatientImmunizationRelatedObservationType |
CLSSRM | http://hl7.org/fhir/v3/ActCode | classroom |
GRADE | http://hl7.org/fhir/v3/ActCode | grade |
SCHL | http://hl7.org/fhir/v3/ActCode | school |
SCHLDIV | http://hl7.org/fhir/v3/ActCode | school division |
TEACHER | http://hl7.org/fhir/v3/ActCode | teacher |
_PopulationInclusionObservationType | http://hl7.org/fhir/v3/ActCode | PopulationInclusionObservationType |
DENEX | http://hl7.org/fhir/v3/ActCode | denominator exclusions |
DENEXCEP | http://hl7.org/fhir/v3/ActCode | denominator exceptions |
DENOM | http://hl7.org/fhir/v3/ActCode | denominator |
IPOP | http://hl7.org/fhir/v3/ActCode | initial population |
IPPOP | http://hl7.org/fhir/v3/ActCode | initial patient population |
MSRPOPL | http://hl7.org/fhir/v3/ActCode | measure population |
MSRPOPLEX | http://hl7.org/fhir/v3/ActCode | measure population exclusions |
NUMER | http://hl7.org/fhir/v3/ActCode | numerator |
NUMEX | http://hl7.org/fhir/v3/ActCode | numerator exclusions |
_PreferenceObservationType | http://hl7.org/fhir/v3/ActCode | _PreferenceObservationType |
PREFSTRENGTH | http://hl7.org/fhir/v3/ActCode | preference strength |
ADVERSE_REACTION | http://hl7.org/fhir/v3/ActCode | Adverse Reaction |
ASSERTION | http://hl7.org/fhir/v3/ActCode | Assertion |
CASESER | http://hl7.org/fhir/v3/ActCode | case seriousness criteria |
CDIO | http://hl7.org/fhir/v3/ActCode | case disease imported observation |
CRIT | http://hl7.org/fhir/v3/ActCode | criticality |
CTMO | http://hl7.org/fhir/v3/ActCode | case transmission mode observation |
DX | http://hl7.org/fhir/v3/ActCode | ObservationDiagnosisTypes |
ADMDX | http://hl7.org/fhir/v3/ActCode | admitting diagnosis |
DISDX | http://hl7.org/fhir/v3/ActCode | discharge diagnosis |
INTDX | http://hl7.org/fhir/v3/ActCode | intermediate diagnosis |
NOI | http://hl7.org/fhir/v3/ActCode | nature of injury |
GISTIER | http://hl7.org/fhir/v3/ActCode | GIS tier |
HHOBS | http://hl7.org/fhir/v3/ActCode | household situation observation |
ISSUE | http://hl7.org/fhir/v3/ActCode | detected issue |
_ActAdministrativeDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | ActAdministrativeDetectedIssueCode |
_ActAdministrativeAuthorizationDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | ActAdministrativeAuthorizationDetectedIssueCode |
NAT | http://hl7.org/fhir/v3/ActCode | Insufficient authorization |
SUPPRESSED | http://hl7.org/fhir/v3/ActCode | record suppressed |
VALIDAT | http://hl7.org/fhir/v3/ActCode | validation issue |
KEY204 | http://hl7.org/fhir/v3/ActCode | Unknown key identifier |
KEY205 | http://hl7.org/fhir/v3/ActCode | Duplicate key identifier |
COMPLY | http://hl7.org/fhir/v3/ActCode | Compliance Alert |
DUPTHPY | http://hl7.org/fhir/v3/ActCode | Duplicate Therapy Alert |
DUPTHPCLS | http://hl7.org/fhir/v3/ActCode | duplicate therapeutic alass alert |
DUPTHPGEN | http://hl7.org/fhir/v3/ActCode | duplicate generic alert |
ABUSE | http://hl7.org/fhir/v3/ActCode | commonly abused/misused alert |
FRAUD | http://hl7.org/fhir/v3/ActCode | potential fraud |
PLYDOC | http://hl7.org/fhir/v3/ActCode | Poly-orderer Alert |
PLYPHRM | http://hl7.org/fhir/v3/ActCode | Poly-supplier Alert |
DOSE | http://hl7.org/fhir/v3/ActCode | Dosage problem |
DOSECOND | http://hl7.org/fhir/v3/ActCode | dosage-condition alert |
DOSEDUR | http://hl7.org/fhir/v3/ActCode | Dose-Duration Alert |
DOSEDURH | http://hl7.org/fhir/v3/ActCode | Dose-Duration High Alert |
DOSEDURHIND | http://hl7.org/fhir/v3/ActCode | Dose-Duration High for Indication Alert |
DOSEDURL | http://hl7.org/fhir/v3/ActCode | Dose-Duration Low Alert |
DOSEDURLIND | http://hl7.org/fhir/v3/ActCode | Dose-Duration Low for Indication Alert |
DOSEH | http://hl7.org/fhir/v3/ActCode | High Dose Alert |
DOSEHINDA | http://hl7.org/fhir/v3/ActCode | High Dose for Age Alert |
DOSEHIND | http://hl7.org/fhir/v3/ActCode | High Dose for Indication Alert |
DOSEHINDSA | http://hl7.org/fhir/v3/ActCode | High Dose for Height/Surface Area Alert |
DOSEHINDW | http://hl7.org/fhir/v3/ActCode | High Dose for Weight Alert |
DOSEIVL | http://hl7.org/fhir/v3/ActCode | Dose-Interval Alert |
DOSEIVLIND | http://hl7.org/fhir/v3/ActCode | Dose-Interval for Indication Alert |
DOSEL | http://hl7.org/fhir/v3/ActCode | Low Dose Alert |
DOSELINDA | http://hl7.org/fhir/v3/ActCode | Low Dose for Age Alert |
DOSELIND | http://hl7.org/fhir/v3/ActCode | Low Dose for Indication Alert |
DOSELINDSA | http://hl7.org/fhir/v3/ActCode | Low Dose for Height/Surface Area Alert |
DOSELINDW | http://hl7.org/fhir/v3/ActCode | Low Dose for Weight Alert |
MDOSE | http://hl7.org/fhir/v3/ActCode | maximum dosage reached |
OBSA | http://hl7.org/fhir/v3/ActCode | Observation Alert |
AGE | http://hl7.org/fhir/v3/ActCode | Age Alert |
ADALRT | http://hl7.org/fhir/v3/ActCode | adult alert |
GEALRT | http://hl7.org/fhir/v3/ActCode | geriatric alert |
PEALRT | http://hl7.org/fhir/v3/ActCode | pediatric alert |
COND | http://hl7.org/fhir/v3/ActCode | Condition Alert |
HGHT | http://hl7.org/fhir/v3/ActCode | HGHT |
LACT | http://hl7.org/fhir/v3/ActCode | Lactation Alert |
PREG | http://hl7.org/fhir/v3/ActCode | Pregnancy Alert |
WGHT | http://hl7.org/fhir/v3/ActCode | WGHT |
CREACT | http://hl7.org/fhir/v3/ActCode | common reaction alert |
GEN | http://hl7.org/fhir/v3/ActCode | Genetic Alert |
GEND | http://hl7.org/fhir/v3/ActCode | Gender Alert |
LAB | http://hl7.org/fhir/v3/ActCode | Lab Alert |
REACT | http://hl7.org/fhir/v3/ActCode | Reaction Alert |
ALGY | http://hl7.org/fhir/v3/ActCode | Allergy Alert |
INT | http://hl7.org/fhir/v3/ActCode | Intolerance Alert |
RREACT | http://hl7.org/fhir/v3/ActCode | Related Reaction Alert |
RALG | http://hl7.org/fhir/v3/ActCode | Related Allergy Alert |
RAR | http://hl7.org/fhir/v3/ActCode | Related Prior Reaction Alert |
RINT | http://hl7.org/fhir/v3/ActCode | Related Intolerance Alert |
BUS | http://hl7.org/fhir/v3/ActCode | business constraint violation |
CODE_INVAL | http://hl7.org/fhir/v3/ActCode | code is not valid |
CODE_DEPREC | http://hl7.org/fhir/v3/ActCode | code has been deprecated |
FORMAT | http://hl7.org/fhir/v3/ActCode | invalid format |
ILLEGAL | http://hl7.org/fhir/v3/ActCode | illegal |
LEN_RANGE | http://hl7.org/fhir/v3/ActCode | length out of range |
LEN_LONG | http://hl7.org/fhir/v3/ActCode | length is too long |
LEN_SHORT | http://hl7.org/fhir/v3/ActCode | length is too short |
MISSCOND | http://hl7.org/fhir/v3/ActCode | conditional element missing |
MISSMAND | http://hl7.org/fhir/v3/ActCode | mandatory element missing |
NODUPS | http://hl7.org/fhir/v3/ActCode | duplicate values are not permitted |
NOPERSIST | http://hl7.org/fhir/v3/ActCode | element will not be persisted |
REP_RANGE | http://hl7.org/fhir/v3/ActCode | repetitions out of range |
MAXOCCURS | http://hl7.org/fhir/v3/ActCode | repetitions above maximum |
MINOCCURS | http://hl7.org/fhir/v3/ActCode | repetitions below minimum |
_ActAdministrativeRuleDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | ActAdministrativeRuleDetectedIssueCode |
KEY206 | http://hl7.org/fhir/v3/ActCode | non-matching identification |
OBSOLETE | http://hl7.org/fhir/v3/ActCode | obsolete record returned |
_ActSuppliedItemDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | ActSuppliedItemDetectedIssueCode |
_AdministrationDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | AdministrationDetectedIssueCode |
_AppropriatenessDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | AppropriatenessDetectedIssueCode |
_InteractionDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | InteractionDetectedIssueCode |
FOOD | http://hl7.org/fhir/v3/ActCode | Food Interaction Alert |
TPROD | http://hl7.org/fhir/v3/ActCode | Therapeutic Product Alert |
DRG | http://hl7.org/fhir/v3/ActCode | Drug Interaction Alert |
NHP | http://hl7.org/fhir/v3/ActCode | Natural Health Product Alert |
NONRX | http://hl7.org/fhir/v3/ActCode | Non-Prescription Interaction Alert |
PREVINEF | http://hl7.org/fhir/v3/ActCode | previously ineffective |
DACT | http://hl7.org/fhir/v3/ActCode | drug action detected issue |
TIME | http://hl7.org/fhir/v3/ActCode | timing detected issue |
ALRTENDLATE | http://hl7.org/fhir/v3/ActCode | end too late alert |
ALRTSTRTLATE | http://hl7.org/fhir/v3/ActCode | start too late alert |
_TimingDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | TimingDetectedIssueCode |
ENDLATE | http://hl7.org/fhir/v3/ActCode | End Too Late Alert |
STRTLATE | http://hl7.org/fhir/v3/ActCode | Start Too Late Alert |
_SupplyDetectedIssueCode | http://hl7.org/fhir/v3/ActCode | SupplyDetectedIssueCode |
ALLDONE | http://hl7.org/fhir/v3/ActCode | already performed |
FULFIL | http://hl7.org/fhir/v3/ActCode | fulfillment alert |
NOTACTN | http://hl7.org/fhir/v3/ActCode | no longer actionable |
NOTEQUIV | http://hl7.org/fhir/v3/ActCode | not equivalent alert |
NOTEQUIVGEN | http://hl7.org/fhir/v3/ActCode | not generically equivalent alert |
NOTEQUIVTHER | http://hl7.org/fhir/v3/ActCode | not therapeutically equivalent alert |
TIMING | http://hl7.org/fhir/v3/ActCode | event timing incorrect alert |
INTERVAL | http://hl7.org/fhir/v3/ActCode | outside requested time |
MINFREQ | http://hl7.org/fhir/v3/ActCode | too soon within frequency based on the usage |
HELD | http://hl7.org/fhir/v3/ActCode | held/suspended alert |
TOOLATE | http://hl7.org/fhir/v3/ActCode | Refill Too Late Alert |
TOOSOON | http://hl7.org/fhir/v3/ActCode | Refill Too Soon Alert |
HISTORIC | http://hl7.org/fhir/v3/ActCode | record recorded as historical |
PATPREF | http://hl7.org/fhir/v3/ActCode | violates stated preferences |
PATPREFALT | http://hl7.org/fhir/v3/ActCode | violates stated preferences, alternate available |
KSUBJ | http://hl7.org/fhir/v3/ActCode | knowledge subject |
KSUBT | http://hl7.org/fhir/v3/ActCode | knowledge subtopic |
OINT | http://hl7.org/fhir/v3/ActCode | intolerance |
ALG | http://hl7.org/fhir/v3/ActCode | Allergy |
DALG | http://hl7.org/fhir/v3/ActCode | Drug Allergy |
EALG | http://hl7.org/fhir/v3/ActCode | Environmental Allergy |
FALG | http://hl7.org/fhir/v3/ActCode | Food Allergy |
DINT | http://hl7.org/fhir/v3/ActCode | Drug Intolerance |
DNAINT | http://hl7.org/fhir/v3/ActCode | Drug Non-Allergy Intolerance |
EINT | http://hl7.org/fhir/v3/ActCode | Environmental Intolerance |
ENAINT | http://hl7.org/fhir/v3/ActCode | Environmental Non-Allergy Intolerance |
FINT | http://hl7.org/fhir/v3/ActCode | Food Intolerance |
FNAINT | http://hl7.org/fhir/v3/ActCode | Food Non-Allergy Intolerance |
NAINT | http://hl7.org/fhir/v3/ActCode | Non-Allergy Intolerance |
SEV | http://hl7.org/fhir/v3/ActCode | Severity Observation |
_FDALabelData | http://hl7.org/fhir/v3/ActCode | FDALabelData |
FDACOATING | http://hl7.org/fhir/v3/ActCode | coating |
FDACOLOR | http://hl7.org/fhir/v3/ActCode | color |
FDAIMPRINTCD | http://hl7.org/fhir/v3/ActCode | imprint code |
FDALOGO | http://hl7.org/fhir/v3/ActCode | logo |
FDASCORING | http://hl7.org/fhir/v3/ActCode | scoring |
FDASHAPE | http://hl7.org/fhir/v3/ActCode | shape |
FDASIZE | http://hl7.org/fhir/v3/ActCode | size |
1-8 | http://loinc.org | Acyclovir [Susceptibility] |
10-9 | http://loinc.org | Amdinocillin [Susceptibility] by Serum bactericidal titer |
100-8 | http://loinc.org | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
1000-9 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
10000-8 | http://loinc.org | R wave duration in lead AVR |
10001-6 | http://loinc.org | R wave duration in lead I |
10002-4 | http://loinc.org | R wave duration in lead II |
10003-2 | http://loinc.org | R wave duration in lead III |
10004-0 | http://loinc.org | R wave duration in lead V1 |
10005-7 | http://loinc.org | R wave duration in lead V2 |
10006-5 | http://loinc.org | R wave duration in lead V3 |
10007-3 | http://loinc.org | R wave duration in lead V4 |
10008-1 | http://loinc.org | R wave duration in lead V5 |
10009-9 | http://loinc.org | R wave duration in lead V6 |
1001-7 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma from donor |
10010-7 | http://loinc.org | R' wave amplitude in lead AVF |
10011-5 | http://loinc.org | R' wave amplitude in lead AVL |
10012-3 | http://loinc.org | R' wave amplitude in lead AVR |
10013-1 | http://loinc.org | R' wave amplitude in lead I |
10014-9 | http://loinc.org | R' wave amplitude in lead II |
10015-6 | http://loinc.org | R' wave amplitude in lead III |
10016-4 | http://loinc.org | R' wave amplitude in lead V1 |
10017-2 | http://loinc.org | R' wave amplitude in lead V2 |
10018-0 | http://loinc.org | R' wave amplitude in lead V3 |
10019-8 | http://loinc.org | R' wave amplitude in lead V4 |
1002-5 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma |
10020-6 | http://loinc.org | R' wave amplitude in lead V5 |
10021-4 | http://loinc.org | R' wave amplitude in lead V6 |
10022-2 | http://loinc.org | R' wave duration in lead AVF |
10023-0 | http://loinc.org | R' wave duration in lead AVL |
10024-8 | http://loinc.org | R' wave duration in lead AVR |
10025-5 | http://loinc.org | R' wave duration in lead I |
10026-3 | http://loinc.org | R' wave duration in lead II |
10027-1 | http://loinc.org | R' wave duration in lead III |
10028-9 | http://loinc.org | R' wave duration in lead V1 |
10029-7 | http://loinc.org | R' wave duration in lead V2 |
1003-3 | http://loinc.org | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
10030-5 | http://loinc.org | R' wave duration in lead V3 |
10031-3 | http://loinc.org | R' wave duration in lead V4 |
10032-1 | http://loinc.org | R' wave duration in lead V5 |
10033-9 | http://loinc.org | R' wave duration in lead V6 |
10034-7 | http://loinc.org | S wave amplitude in lead AVF |
10035-4 | http://loinc.org | S wave amplitude in lead AVL |
10036-2 | http://loinc.org | S wave amplitude in lead AVR |
10037-0 | http://loinc.org | S wave amplitude in lead I |
10038-8 | http://loinc.org | S wave amplitude in lead II |
10039-6 | http://loinc.org | S wave amplitude in lead III |
1004-1 | http://loinc.org | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
10040-4 | http://loinc.org | S wave amplitude in lead V1 |
10041-2 | http://loinc.org | S wave amplitude in lead V2 |
10042-0 | http://loinc.org | S wave amplitude in lead V3 |
10043-8 | http://loinc.org | S wave amplitude in lead V4 |
10044-6 | http://loinc.org | S wave amplitude in lead V5 |
10045-3 | http://loinc.org | S wave amplitude in lead V6 |
10046-1 | http://loinc.org | S wave duration in lead AVF |
10047-9 | http://loinc.org | S wave duration in lead AVL |
10048-7 | http://loinc.org | S wave duration in lead AVR |
10049-5 | http://loinc.org | S wave duration in lead I |
1005-8 | http://loinc.org | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
10050-3 | http://loinc.org | S wave duration in lead II |
10051-1 | http://loinc.org | S wave duration in lead III |
10052-9 | http://loinc.org | S wave duration in lead V1 |
10053-7 | http://loinc.org | S wave duration in lead V2 |
10054-5 | http://loinc.org | S wave duration in lead V3 |
10055-2 | http://loinc.org | S wave duration in lead V4 |
10056-0 | http://loinc.org | S wave duration in lead V5 |
10057-8 | http://loinc.org | S wave duration in lead V6 |
10058-6 | http://loinc.org | S' wave amplitude in lead AVF |
10059-4 | http://loinc.org | S' wave amplitude in lead AVL |
1006-6 | http://loinc.org | Direct antiglobulin test.IgG specific reagent [interpretation] on Red Blood Cells |
10060-2 | http://loinc.org | S' wave amplitude in lead AVR |
10061-0 | http://loinc.org | S' wave amplitude in lead I |
10062-8 | http://loinc.org | S' wave amplitude in lead II |
10063-6 | http://loinc.org | S' wave amplitude in lead III |
10064-4 | http://loinc.org | S' wave amplitude in lead V1 |
10065-1 | http://loinc.org | S' wave amplitude in lead V2 |
10066-9 | http://loinc.org | S' wave amplitude in lead V3 |
10067-7 | http://loinc.org | S' wave amplitude in lead V4 |
10068-5 | http://loinc.org | S' wave amplitude in lead V5 |
10069-3 | http://loinc.org | S' wave amplitude in lead V6 |
1007-4 | http://loinc.org | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
10070-1 | http://loinc.org | S' wave duration in lead AVF |
10071-9 | http://loinc.org | S' wave duration in lead AVL |
10072-7 | http://loinc.org | S' wave duration in lead AVR |
10073-5 | http://loinc.org | S' wave duration in lead I |
10074-3 | http://loinc.org | S' wave duration in lead II |
10075-0 | http://loinc.org | S' wave duration in lead III |
10076-8 | http://loinc.org | S' wave duration in lead V1 |
10077-6 | http://loinc.org | S' wave duration in lead V2 |
10078-4 | http://loinc.org | S' wave duration in lead V3 |
10079-2 | http://loinc.org | S' wave duration in lead V4 |
1008-2 | http://loinc.org | Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma |
10080-0 | http://loinc.org | S' wave duration in lead V5 |
10081-8 | http://loinc.org | S' wave duration in lead V6 |
10082-6 | http://loinc.org | ST initial amplitude 6 ms in lead AVF |
10083-4 | http://loinc.org | ST initial amplitude 6 ms in lead AVL |
10084-2 | http://loinc.org | ST initial amplitude 6 ms in lead AVR |
10085-9 | http://loinc.org | ST initial amplitude 6 ms in lead I |
10086-7 | http://loinc.org | ST initial amplitude 6 ms in lead II |
10087-5 | http://loinc.org | ST initial amplitude 6 ms in lead III |
10088-3 | http://loinc.org | ST initial amplitude 6 ms in lead V1 |
10089-1 | http://loinc.org | ST initial amplitude 6 ms in lead V2 |
1009-0 | http://loinc.org | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
10090-9 | http://loinc.org | ST initial amplitude 6 ms in lead V3 |
10091-7 | http://loinc.org | ST initial amplitude 6 ms in lead V4 |
10092-5 | http://loinc.org | ST initial amplitude 6 ms in lead V5 |
10093-3 | http://loinc.org | ST initial amplitude 6 ms in lead V6 |
10094-1 | http://loinc.org | ST slope in lead AVF |
10095-8 | http://loinc.org | ST slope in lead AVL |
10096-6 | http://loinc.org | ST slope in lead AVR |
10097-4 | http://loinc.org | ST slope in lead I |
10098-2 | http://loinc.org | ST slope in lead II |
10099-0 | http://loinc.org | ST slope in lead III |
101-6 | http://loinc.org | Cefoperazone [Susceptibility] by Disk diffusion (KB) |
1010-8 | http://loinc.org | Ew Ab [Presence] in Serum or Plasma from Blood product unit |
10100-6 | http://loinc.org | ST slope in lead V1 |
10101-4 | http://loinc.org | ST slope in lead V2 |
10102-2 | http://loinc.org | ST slope in lead V3 |
10103-0 | http://loinc.org | ST slope in lead V4 |
10104-8 | http://loinc.org | ST slope in lead V5 |
10105-5 | http://loinc.org | ST slope in lead V6 |
10106-3 | http://loinc.org | ST wave end displacement in lead AVF |
10107-1 | http://loinc.org | ST wave end displacement in lead AVL |
10108-9 | http://loinc.org | ST wave end displacement in lead AVR |
10109-7 | http://loinc.org | ST wave end displacement in lead I |
1011-6 | http://loinc.org | Ew Ab [Presence] in Serum or Plasma from donor |
10110-5 | http://loinc.org | ST wave end displacement in lead II |
10111-3 | http://loinc.org | ST wave end displacement in lead III |
10112-1 | http://loinc.org | ST wave end displacement in lead V1 |
10113-9 | http://loinc.org | ST wave end displacement in lead V2 |
10114-7 | http://loinc.org | ST wave end displacement in lead V3 |
10115-4 | http://loinc.org | ST wave end displacement in lead V4 |
10116-2 | http://loinc.org | ST wave end displacement in lead V5 |
10117-0 | http://loinc.org | ST wave end displacement in lead V6 |
10118-8 | http://loinc.org | ST wave mid displacement in lead AVF |
10119-6 | http://loinc.org | ST wave mid displacement in lead AVL |
1012-4 | http://loinc.org | Ew Ab [Presence] in Serum or Plasma |
10120-4 | http://loinc.org | ST wave mid displacement in lead AVR |
10121-2 | http://loinc.org | ST wave mid displacement in lead I |
10122-0 | http://loinc.org | ST wave mid displacement in lead II |
10123-8 | http://loinc.org | ST wave mid displacement in lead III |
10124-6 | http://loinc.org | ST wave mid displacement in lead V1 |
10125-3 | http://loinc.org | ST wave mid displacement in lead V2 |
10126-1 | http://loinc.org | ST wave mid displacement in lead V3 |
10127-9 | http://loinc.org | ST wave mid displacement in lead V4 |
10128-7 | http://loinc.org | ST wave mid displacement in lead V5 |
10129-5 | http://loinc.org | ST wave mid displacement in lead V6 |
1013-2 | http://loinc.org | Ew Ag [Presence] on Red Blood Cells from Blood product unit |
10130-3 | http://loinc.org | T' wave amplitude in lead AVF |
10131-1 | http://loinc.org | T' wave amplitude in lead AVL |
10132-9 | http://loinc.org | T' wave amplitude in lead AVR |
10133-7 | http://loinc.org | T' wave amplitude in lead I |
10134-5 | http://loinc.org | T' wave amplitude in lead II |
10135-2 | http://loinc.org | T' wave amplitude in lead III |
10136-0 | http://loinc.org | T' wave amplitude in lead V1 |
10137-8 | http://loinc.org | T' wave amplitude in lead V2 |
10138-6 | http://loinc.org | T' wave amplitude in lead V3 |
10139-4 | http://loinc.org | T' wave amplitude in lead V4 |
1014-0 | http://loinc.org | Ew Ag [Presence] on Red Blood Cells from donor |
10140-2 | http://loinc.org | T' wave amplitude in lead V5 |
10141-0 | http://loinc.org | T' wave amplitude in lead V6 |
10142-8 | http://loinc.org | T wave amplitude in lead AVF |
10143-6 | http://loinc.org | T wave amplitude in lead AVL |
10144-4 | http://loinc.org | T wave amplitude in lead AVR |
10145-1 | http://loinc.org | T wave amplitude in lead I |
10146-9 | http://loinc.org | T wave amplitude in lead II |
10147-7 | http://loinc.org | T wave amplitude in lead III |
10148-5 | http://loinc.org | T wave amplitude in lead V1 |
10149-3 | http://loinc.org | T wave amplitude in lead V2 |
1015-7 | http://loinc.org | Ew Ag [Presence] on Red Blood Cells |
10150-1 | http://loinc.org | T wave amplitude in lead V3 |
10151-9 | http://loinc.org | T wave amplitude in lead V4 |
10152-7 | http://loinc.org | T wave amplitude in lead V5 |
10153-5 | http://loinc.org | T wave amplitude in lead V6 |
10154-3 | http://loinc.org | Chief complaint Narrative - Reported |
10155-0 | http://loinc.org | History of allergies, reported |
10156-8 | http://loinc.org | History of childhood diseases Narrative |
10157-6 | http://loinc.org | History of family member diseases Narrative |
10158-4 | http://loinc.org | History of functional status Narrative |
10159-2 | http://loinc.org | History of industrial exposure Narrative |
1016-5 | http://loinc.org | E Ab [Presence] in Serum or Plasma from Blood product unit |
10160-0 | http://loinc.org | History of medication use Narrative |
10161-8 | http://loinc.org | History of occupational exposure Narrative |
10162-6 | http://loinc.org | History of pregnancies Narrative |
10163-4 | http://loinc.org | History of pregnancies |
10164-2 | http://loinc.org | History of present illness Narrative |
10165-9 | http://loinc.org | Deprecated History of psychiatric symptoms and diseases Narrative |
10166-7 | http://loinc.org | History of social function Narrative |
10167-5 | http://loinc.org | History of surgical procedures Narrative |
10168-3 | http://loinc.org | History of Cardiovascular system disorders Narrative |
10169-1 | http://loinc.org | History of Ear disorders Narrative |
1017-3 | http://loinc.org | E Ab [Presence] in Serum or Plasma from donor |
10170-9 | http://loinc.org | History of Endocrine system disorders Narrative |
10171-7 | http://loinc.org | History of Eyes disorders Narrative |
10172-5 | http://loinc.org | History of Hematologic system disorders Narrative |
10173-3 | http://loinc.org | History of Musculoskeletal system disorders Narrative |
10174-1 | http://loinc.org | History of Nose disorders Narrative |
10175-8 | http://loinc.org | History of Oral cavity disorders Narrative |
10176-6 | http://loinc.org | History of Reproductive system disorders Narrative |
10177-4 | http://loinc.org | History of Respiratory system disorders Narrative |
10178-2 | http://loinc.org | History of Skin disorders Narrative |
10179-0 | http://loinc.org | History of Throat and Neck disorders Narrative |
1018-1 | http://loinc.org | E Ab [Presence] in Serum or Plasma |
10180-8 | http://loinc.org | History of Throat and Neck disorders |
10181-6 | http://loinc.org | History of Urinary tract disorders Narrative |
10182-4 | http://loinc.org | History of travel Narrative |
10183-2 | http://loinc.org | Hospital discharge medications Narrative |
10184-0 | http://loinc.org | Hospital discharge physical findings Narrative |
10185-7 | http://loinc.org | Hospital discharge procedures Narrative |
10186-5 | http://loinc.org | Identifying information Narrative Observed |
10187-3 | http://loinc.org | Review of systems Narrative - Reported |
10188-1 | http://loinc.org | Review of systems overview Narrative - Reported |
10189-9 | http://loinc.org | Review of systems overview - Reported |
1019-9 | http://loinc.org | E Ag [Presence] on Red Blood Cells from Blood product unit |
10190-7 | http://loinc.org | Mental status Narrative |
10191-5 | http://loinc.org | Physical findings of Abdomen Narrative |
10192-3 | http://loinc.org | Physical findings of Back Narrative |
10193-1 | http://loinc.org | Physical findings of Breasts Narrative |
10194-9 | http://loinc.org | Physical findings of Neurologic deep tendon reflexes Narrative |
10195-6 | http://loinc.org | Physical findings of Ear Narrative |
10196-4 | http://loinc.org | Physical findings of Extremities Narrative |
10197-2 | http://loinc.org | Physical findings of Eye Narrative |
10198-0 | http://loinc.org | Physical findings of Genitourinary tract Narrative |
10199-8 | http://loinc.org | Physical findings of Head Narrative |
102-4 | http://loinc.org | Cefoperazone [Susceptibility] by Serum bactericidal titer |
1020-7 | http://loinc.org | E Ag [Presence] on Red Blood Cells from donor |
10200-4 | http://loinc.org | Physical findings of Heart Narrative |
10201-2 | http://loinc.org | Physical findings of Mouth and Throat and Teeth Narrative |
10202-0 | http://loinc.org | Physical findings of Nervous system Narrative |
10203-8 | http://loinc.org | Physical findings of Nose Narrative |
10204-6 | http://loinc.org | Physical findings of Pelvis Narrative |
10205-3 | http://loinc.org | Physical findings of Rectum Narrative |
10206-1 | http://loinc.org | Physical findings of Skin Narrative |
10207-9 | http://loinc.org | Physical findings of Thorax and Lungs Narrative |
10208-7 | http://loinc.org | Physical findings of vessels Narrative |
10209-5 | http://loinc.org | Physical findings of Neurologic balance and Coordination Narrative |
1021-5 | http://loinc.org | E Ag [Presence] on Red Blood Cells |
10210-3 | http://loinc.org | Physical findings of General status Narrative |
10211-1 | http://loinc.org | Physical findings of Sense of touch Narrative |
10212-9 | http://loinc.org | Physical findings of Strength Narrative |
10213-7 | http://loinc.org | Surgical operation note anesthesia Narrative |
10214-5 | http://loinc.org | Surgical operation note anesthesia duration |
10215-2 | http://loinc.org | Surgical operation note findings Narrative |
10216-0 | http://loinc.org | Surgical operation note fluids Narrative |
10217-8 | http://loinc.org | Surgical operation note indications [interpretation] Narrative |
10218-6 | http://loinc.org | Surgical operation note postoperative diagnosis Narrative |
10219-4 | http://loinc.org | Surgical operation note preoperative diagnosis Narrative |
1022-3 | http://loinc.org | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
10220-2 | http://loinc.org | Surgical operation note prep time duration |
10221-0 | http://loinc.org | Surgical operation note specimens taken Narrative |
10222-8 | http://loinc.org | Surgical operation note surgical complications [interpretation] Narrative |
10223-6 | http://loinc.org | Surgical operation note surgical procedure Narrative |
10224-4 | http://loinc.org | Hemodynamic method special circumstances |
10225-1 | http://loinc.org | Cardiac measurement device Institution inventory number |
10226-9 | http://loinc.org | Oxygen content in Intravascular space |
10227-7 | http://loinc.org | Cardiac measurement device Vendor model number |
10228-5 | http://loinc.org | Cardiac measurement device Vendor serial number |
10229-3 | http://loinc.org | Hemodynamic method Type of |
1023-1 | http://loinc.org | Fy sup(a) Ab [Presence] in Serum or Plasma from donor |
10230-1 | http://loinc.org | Left ventricular Ejection fraction |
10231-9 | http://loinc.org | Right ventricular Ejection fraction |
10232-7 | http://loinc.org | Oxygen content in Aortic root |
10233-5 | http://loinc.org | Oxygen content in Left atrium |
10234-3 | http://loinc.org | Oxygen content in Right atrium |
10235-0 | http://loinc.org | Oxygen content in High right atrium |
10236-8 | http://loinc.org | Oxygen content in Low right atrium |
10237-6 | http://loinc.org | Oxygen content in Mid right atrium |
10238-4 | http://loinc.org | Oxygen content in Left ventricle |
10239-2 | http://loinc.org | Oxygen content in Right ventricular outflow tract |
1024-9 | http://loinc.org | Fy sup(a) Ab [Presence] in Serum or Plasma |
10240-0 | http://loinc.org | Oxygen content in Right ventricle |
10241-8 | http://loinc.org | Oxygen content in Coronary sinus |
10242-6 | http://loinc.org | Oxygen content in Ductus arteriosus |
10243-4 | http://loinc.org | Oxygen content in Inferior vena cava |
10244-2 | http://loinc.org | Oxygen content in Pulmonary artery - left |
10245-9 | http://loinc.org | Oxygen content in Main pulmonary artery |
10246-7 | http://loinc.org | Oxygen content in Pulmonary artery - right |
10247-5 | http://loinc.org | Oxygen content in Pulmonary wedge |
10248-3 | http://loinc.org | Oxygen content in Superior vena cava |
10249-1 | http://loinc.org | Heart rate device Institution inventory number |
1025-6 | http://loinc.org | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
10250-9 | http://loinc.org | Heart rate device Vendor model number |
10251-7 | http://loinc.org | Heart rate device Vendor serial number |
10252-5 | http://loinc.org | Biliary drain site |
10253-3 | http://loinc.org | Type of Biliary drain |
10254-1 | http://loinc.org | Type of Peritoneal drain |
10255-8 | http://loinc.org | Type of Subarachnoid drain |
10256-6 | http://loinc.org | Biliary drain Institution inventory number |
10257-4 | http://loinc.org | Chest tube Institution inventory number |
10258-2 | http://loinc.org | Enteral tube Institution inventory number |
10259-0 | http://loinc.org | Gastrostomy tube Institution inventory number |
1026-4 | http://loinc.org | Fy sup(a) Ag [Presence] on Red Blood Cells from donor |
10260-8 | http://loinc.org | GI tube Institution inventory number |
10261-6 | http://loinc.org | Intravascular tube Institution inventory number |
10262-4 | http://loinc.org | IO tube Institution inventory number |
10263-2 | http://loinc.org | Nasogastric tube Institution inventory number |
10264-0 | http://loinc.org | Oral tube Institution inventory number |
10265-7 | http://loinc.org | Peritoneal drain Institution inventory number |
10266-5 | http://loinc.org | Peritoneal tube Institution inventory number |
10267-3 | http://loinc.org | Rate control device Institution inventory number |
10268-1 | http://loinc.org | Stool collection device Institution inventory number |
10269-9 | http://loinc.org | Subarachnoid drain Institution inventory number |
1027-2 | http://loinc.org | Fy sup(a) Ag [Presence] on Red Blood Cells |
10270-7 | http://loinc.org | Synovial drain Institution inventory number |
10271-5 | http://loinc.org | Tube or drain Institution inventory number |
10272-3 | http://loinc.org | Upper GI tube Institution inventory number |
10273-1 | http://loinc.org | Bladder irrigation tube Institution inventory number |
10274-9 | http://loinc.org | Urine tube Institution inventory number |
10275-6 | http://loinc.org | Wound drain device Institution inventory number |
10276-4 | http://loinc.org | Peritoneal drain site |
10277-2 | http://loinc.org | Stool collection site |
10278-0 | http://loinc.org | Subarachnoid drain site |
10279-8 | http://loinc.org | Biliary drain Vendor model number |
1028-0 | http://loinc.org | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
10280-6 | http://loinc.org | Chest tube Vendor model number |
10281-4 | http://loinc.org | Enteral tube Vendor model number |
10282-2 | http://loinc.org | Gastrostomy tube Vendor model number |
10283-0 | http://loinc.org | GI tube Vendor model number |
10284-8 | http://loinc.org | Intravascular tube Vendor model number |
10285-5 | http://loinc.org | IO tube Vendor model number |
10286-3 | http://loinc.org | Nasogastric tube Vendor model number |
10287-1 | http://loinc.org | Oral tube Vendor model number |
10288-9 | http://loinc.org | Peritoneal drain Vendor model number |
10289-7 | http://loinc.org | Peritoneal tube Vendor model number |
1029-8 | http://loinc.org | Fy sup(b) Ab [Presence] in Serum or Plasma from donor |
10290-5 | http://loinc.org | Rate control device Vendor model number |
10291-3 | http://loinc.org | Stool collection device Vendor model number |
10292-1 | http://loinc.org | Subarachnoid drain Vendor model number |
10293-9 | http://loinc.org | Synovial drain Vendor model number |
10294-7 | http://loinc.org | Tube or drain Vendor model number |
10295-4 | http://loinc.org | Upper GI tube Vendor model number |
10296-2 | http://loinc.org | Bladder irrigation tube Vendor model number |
10297-0 | http://loinc.org | Urine tube Vendor model number |
10298-8 | http://loinc.org | Wound drain device Vendor model number |
10299-6 | http://loinc.org | Biliary drain Vendor serial number |
103-2 | http://loinc.org | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |
1030-6 | http://loinc.org | Fy sup(b) Ab [Presence] in Serum or Plasma |
10300-2 | http://loinc.org | Chest tube Vendor serial number |
10301-0 | http://loinc.org | Enteral tube Vendor serial number |
10302-8 | http://loinc.org | Gastrostomy tube Vendor serial number |
10303-6 | http://loinc.org | GI tube Vendor serial number |
10304-4 | http://loinc.org | Intravascular tube Vendor serial number |
10305-1 | http://loinc.org | IO tube Vendor serial number |
10306-9 | http://loinc.org | Nasogastric tube Vendor serial number |
10307-7 | http://loinc.org | Oral tube Vendor serial number |
10308-5 | http://loinc.org | Peritoneal drain Vendor serial number |
10309-3 | http://loinc.org | Peritoneal tube Vendor serial number |
1031-4 | http://loinc.org | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
10310-1 | http://loinc.org | Rate control device Vendor serial number |
10311-9 | http://loinc.org | Stool collection device Vendor serial number |
10312-7 | http://loinc.org | Subarachnoid drain Vendor serial number |
10313-5 | http://loinc.org | Synovial drain Vendor serial number |
10314-3 | http://loinc.org | Tube or drain Vendor serial number |
10315-0 | http://loinc.org | Upper GI tube Vendor serial number |
10316-8 | http://loinc.org | Bladder irrigation tube Vendor serial number |
10317-6 | http://loinc.org | Urine tube Vendor serial number |
10318-4 | http://loinc.org | Wound drain device Vendor serial number |
10319-2 | http://loinc.org | Enema device Institution inventory number |
1032-2 | http://loinc.org | Fy sup(b) Ag [Presence] on Red Blood Cells from donor |
10320-0 | http://loinc.org | Enema device Vendor model number |
10321-8 | http://loinc.org | Enema device Vendor serial number |
10322-6 | http://loinc.org | Potassium intake 24 hour |
10323-4 | http://loinc.org | Wound drain fluid [Appearance] Lower GI tract |
10324-2 | http://loinc.org | Breath rate device Institution inventory number |
10325-9 | http://loinc.org | Breath rate device Vendor model number |
10326-7 | http://loinc.org | Breath rate device Vendor serial number |
10327-5 | http://loinc.org | Eosinophils/100 leukocytes in Sputum by Manual count |
10328-3 | http://loinc.org | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
10329-1 | http://loinc.org | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
1033-0 | http://loinc.org | Fy sup(b) Ag [Presence] on Red Blood Cells |
10330-9 | http://loinc.org | Monocytes/100 leukocytes in Body fluid by Manual count |
10331-7 | http://loinc.org | Rh [Type] in Blood |
10332-5 | http://loinc.org | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
10333-3 | http://loinc.org | Appearance of Cerebral spinal fluid |
10334-1 | http://loinc.org | Cancer Ag 125 [Units/volume] in Serum or Plasma |
10335-8 | http://loinc.org | Color of Cerebral spinal fluid |
10336-6 | http://loinc.org | Gonadotropin peptide [Mass/volume] in Urine |
10337-4 | http://loinc.org | Procollagen peptide.type 1 [Mass/volume] in Serum |
10338-2 | http://loinc.org | Barbiturates [Mass/volume] in Serum or Plasma |
10339-0 | http://loinc.org | Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
1034-8 | http://loinc.org | Fetal cell screen [interpretation] in Blood |
10340-8 | http://loinc.org | Molindone [Mass/volume] in Serum or Plasma |
10341-6 | http://loinc.org | Norpropoxyphene [Mass/volume] in Serum or Plasma |
10342-4 | http://loinc.org | Sulfamethoxazole [Mass/volume] in Serum or Plasma |
10343-2 | http://loinc.org | Temazepam [Mass/volume] in Serum or Plasma |
10344-0 | http://loinc.org | Tranylcypromine [Mass/volume] in Serum or Plasma |
10345-7 | http://loinc.org | Trihexyphenidyl [Mass/volume] in Urine |
10346-5 | http://loinc.org | Hemoglobin A [Units/volume] in Blood by Electrophoresis |
10347-3 | http://loinc.org | Babesia microti identified in Blood by Light microscopy |
10348-1 | http://loinc.org | Bordetella parapertussis Ab [Presence] in Serum |
10349-9 | http://loinc.org | Brucella sp Ab [Units/volume] in Serum |
1035-5 | http://loinc.org | Fresh frozen plasma given [Volume] |
10350-7 | http://loinc.org | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
10351-5 | http://loinc.org | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
10352-3 | http://loinc.org | Bacteria identified in Genital specimen by Aerobe culture |
10353-1 | http://loinc.org | Bacteria identified in Nose by Aerobe culture |
10354-9 | http://loinc.org | Bacteria identified in Urethra by Culture |
10355-6 | http://loinc.org | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
10356-4 | http://loinc.org | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain |
10357-2 | http://loinc.org | Microscopic observation [Identifier] in Wound by Gram stain |
10358-0 | http://loinc.org | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
10359-8 | http://loinc.org | Asialoganglioside GM1 IgM Ab [Titer] in Serum |
1036-3 | http://loinc.org | G Ab [Presence] in Serum or Plasma from Blood product unit |
10360-6 | http://loinc.org | DNA single strand IgG Ab [Units/volume] in Serum |
10361-4 | http://loinc.org | DNA single strand IgM Ab [Units/volume] in Serum |
10362-2 | http://loinc.org | Endomysium IgA Ab [Presence] in Serum |
10363-0 | http://loinc.org | Barbiturates [Presence] in Unspecified specimen |
10364-8 | http://loinc.org | Cotinine [Mass/mass] in Hair |
10365-5 | http://loinc.org | Cotinine [Mass/volume] in Serum or Plasma |
10366-3 | http://loinc.org | Cotinine [Mass/volume] in Urine |
10367-1 | http://loinc.org | Ethanol [Mass/volume] in Gastric fluid |
10368-9 | http://loinc.org | Lead [Mass/volume] in Capillary blood |
10369-7 | http://loinc.org | Opiates [Mass/mass] in Hair |
1037-1 | http://loinc.org | G Ab [Presence] in Serum or Plasma from donor |
10370-5 | http://loinc.org | Phencyclidine [Mass/mass] in Hair |
10371-3 | http://loinc.org | Bite cells [Presence] in Blood by Light microscopy |
10372-1 | http://loinc.org | Blister cells [Presence] in Blood by Light microscopy |
10373-9 | http://loinc.org | Fragments [Presence] in Blood by Light microscopy |
10374-7 | http://loinc.org | Helmet cells [Presence] in Blood by Light microscopy |
10375-4 | http://loinc.org | Irregularly contracted cells [Presence] in Blood by Light microscopy |
10376-2 | http://loinc.org | Oval macrocytes [Presence] in Blood by Light microscopy |
10377-0 | http://loinc.org | Pencil cells [Presence] in Blood by Light microscopy |
10378-8 | http://loinc.org | Polychromasia [Presence] in Blood by Light microscopy |
10379-6 | http://loinc.org | Erythrocytes.dual population [Presence] in Blood by Light microscopy |
1038-9 | http://loinc.org | G Ab [Presence] in Serum or Plasma |
10380-4 | http://loinc.org | Stomatocytes [Presence] in Blood by Light microscopy |
10381-2 | http://loinc.org | Target cells [Presence] in Blood by Light microscopy |
10382-0 | http://loinc.org | A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10383-8 | http://loinc.org | A,B variant NOS Ag [Presence] on Red Blood Cells from donor |
10384-6 | http://loinc.org | A,B variant NOS Ag [Presence] on Red Blood Cells |
10385-3 | http://loinc.org | Albumin concentration given |
10386-1 | http://loinc.org | Albumin given [Volume] |
10387-9 | http://loinc.org | Autologous erythrocytes given [Volume] |
10388-7 | http://loinc.org | Autologous whole blood given [Volume] |
10389-5 | http://loinc.org | Blood product.other [Type] |
1039-7 | http://loinc.org | G Ag [Presence] on Red Blood Cells from Blood product unit |
10390-3 | http://loinc.org | Blood product special preparation [Type] |
10391-1 | http://loinc.org | Cytomegalovirus immune globulin given [Volume] |
10392-9 | http://loinc.org | Cryoprecipitate given [Volume] |
10393-7 | http://loinc.org | Factor IX given [Type] |
10394-5 | http://loinc.org | Factor IX given [Volume] |
10395-2 | http://loinc.org | Factor VIII given [Type] |
10396-0 | http://loinc.org | Factor VIII given [Volume] |
10397-8 | http://loinc.org | Hepatitis B immune globulin given [Volume] |
10398-6 | http://loinc.org | I Ag [Presence] on Red Blood Cells from Blood product unit |
10399-4 | http://loinc.org | I Ag [Presence] on Red Blood Cells from donor |
104-0 | http://loinc.org | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
1040-5 | http://loinc.org | G Ag [Presence] on Red Blood Cells from donor |
10400-0 | http://loinc.org | I Ag [Presence] on Red Blood Cells |
10401-8 | http://loinc.org | Immune serum globulin given [Type] |
10402-6 | http://loinc.org | Immune serum globulin given [Volume] |
10403-4 | http://loinc.org | Inject immune serum globulin [Volume] |
10404-2 | http://loinc.org | Inject Rh immune globulin [Volume] |
10405-9 | http://loinc.org | Inject varicella zoster virus immune globulin [Volume] |
10406-7 | http://loinc.org | little i Ag [Presence] on Red Blood Cells from Blood product unit |
10407-5 | http://loinc.org | little i Ag [Presence] on Red Blood Cells from donor |
10408-3 | http://loinc.org | little i Ag [Presence] on Red Blood Cells |
10409-1 | http://loinc.org | Pentaspan given [Volume] |
1041-3 | http://loinc.org | G Ag [Presence] on Red Blood Cells |
10410-9 | http://loinc.org | Plasma given [Type] |
10411-7 | http://loinc.org | Plasma given [Volume] |
10412-5 | http://loinc.org | Platelets given [Type] |
10413-3 | http://loinc.org | Rh immune globulin given [Volume] |
10414-1 | http://loinc.org | Transfuse albumin [Volume] |
10415-8 | http://loinc.org | Transfuse blood exchange transfusion [Volume] |
10416-6 | http://loinc.org | Transfuse blood product other [Volume] |
10417-4 | http://loinc.org | Transfuse cryoprecipitate [Volume] |
10418-2 | http://loinc.org | Transfuse factor IX [Volume] |
10419-0 | http://loinc.org | Transfuse factor VIII [Volume] |
1042-1 | http://loinc.org | H Ab [Presence] in Serum or Plasma from Blood product unit |
10420-8 | http://loinc.org | Transfuse immune serum globulin [Volume] |
10421-6 | http://loinc.org | Transfuse Pentaspan [Volume] |
10422-4 | http://loinc.org | Transfuse plasma [Volume] |
10423-2 | http://loinc.org | Transfuse platelets [Volume] |
10424-0 | http://loinc.org | Transfuse erythrocytes [Volume] |
10425-7 | http://loinc.org | Transfuse Rh immune globulin [Volume] |
10426-5 | http://loinc.org | Transfuse whole blood [Volume] |
10427-3 | http://loinc.org | Transfuse whole blood autologous [Volume] |
10428-1 | http://loinc.org | Varicella zoster virus immune globulin given [Volume] |
10429-9 | http://loinc.org | AE 1 Ag [Presence] in Tissue by Immune stain |
1043-9 | http://loinc.org | H Ab [Presence] in Serum or Plasma from donor |
10430-7 | http://loinc.org | AE 3 Ag [Presence] in Tissue by Immune stain |
10431-5 | http://loinc.org | B-cell Ag [Presence] in Tissue by Immune stain |
10432-3 | http://loinc.org | CD30 Ag [Presence] in Tissue by Immune stain |
10433-1 | http://loinc.org | BR-2 Ag [Presence] in Tissue by Immune stain |
10434-9 | http://loinc.org | Complement C3 Ag [Presence] in Tissue by Immune stain |
10435-6 | http://loinc.org | C5B-9 Ag [Presence] in Tissue by Immune stain |
10436-4 | http://loinc.org | CD15 Ag [Presence] in Tissue by Immune stain |
10437-2 | http://loinc.org | CD16 Ag [Presence] in Tissue by Immune stain |
10438-0 | http://loinc.org | CD20 Ag [Presence] in Tissue by Immune stain |
10439-8 | http://loinc.org | CD3 Ag [Presence] in Tissue by Immune stain |
1044-7 | http://loinc.org | H Ab [Presence] in Serum |
10440-6 | http://loinc.org | Deprecated CD30 Ag [Presence] in Tissue by Immune stain |
10441-4 | http://loinc.org | CD34 Ag [Presence] in Tissue by Immune stain |
10442-2 | http://loinc.org | CD56 Ag [Presence] in Tissue by Immune stain |
10443-0 | http://loinc.org | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
10444-8 | http://loinc.org | CD57 Ag [Presence] in Tissue by Immune stain |
10445-5 | http://loinc.org | CD11c Ag [Presence] in Tissue by Immune stain |
10446-3 | http://loinc.org | Leukocyte common Ag [Presence] in Tissue by Immune stain |
10447-1 | http://loinc.org | M-5 Ag [Presence] in Tissue by Immune stain |
10448-9 | http://loinc.org | T-cell Ag [Presence] in Tissue by Immune stain |
10449-7 | http://loinc.org | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
1045-4 | http://loinc.org | H NOS Ab [Presence] in Serum or Plasma from Blood product unit |
10450-5 | http://loinc.org | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
10451-3 | http://loinc.org | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
10452-1 | http://loinc.org | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
10453-9 | http://loinc.org | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO |
10454-7 | http://loinc.org | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
10455-4 | http://loinc.org | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO |
10456-2 | http://loinc.org | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting |
10457-0 | http://loinc.org | Actin Ag [Presence] in Tissue by Immune stain |
10458-8 | http://loinc.org | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
10459-6 | http://loinc.org | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
1046-2 | http://loinc.org | H NOS Ab [Presence] in Serum or Plasma from donor |
10460-4 | http://loinc.org | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
10461-2 | http://loinc.org | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
10462-0 | http://loinc.org | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
10463-8 | http://loinc.org | Amyloid A component Ag [Presence] in Tissue by Immune stain |
10464-6 | http://loinc.org | Amyloid P component Ag [Presence] in Tissue by Immune stain |
10465-3 | http://loinc.org | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
10466-1 | http://loinc.org | Anion gap 3 in Serum or Plasma |
10467-9 | http://loinc.org | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
10468-7 | http://loinc.org | Calcitonin Ag [Presence] in Tissue by Immune stain |
10469-5 | http://loinc.org | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
1047-0 | http://loinc.org | H NOS Ab [Presence] in Serum or Plasma |
10470-3 | http://loinc.org | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
10471-1 | http://loinc.org | Chromogranin A Ag [Presence] in Tissue by Immune stain |
10472-9 | http://loinc.org | Chromogranin Ag [Presence] in Tissue by Immune stain |
10473-7 | http://loinc.org | Chymotrypsin Ag [Presence] in Tissue by Immune stain |
10474-5 | http://loinc.org | Collagen type 4 Ag [Presence] in Tissue by Immune stain |
10475-2 | http://loinc.org | Corticotropin Ag [Presence] in Tissue by Immune stain |
10476-0 | http://loinc.org | Desmin Ag [Presence] in Tissue by Immune stain |
10477-8 | http://loinc.org | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
10478-6 | http://loinc.org | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
10479-4 | http://loinc.org | CD227 Ag [Presence] in Tissue by Immune stain |
1048-8 | http://loinc.org | H NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10480-2 | http://loinc.org | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
10481-0 | http://loinc.org | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
10482-8 | http://loinc.org | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
10483-6 | http://loinc.org | Gastrin Ag [Presence] in Tissue by Immune stain |
10484-4 | http://loinc.org | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
10485-1 | http://loinc.org | Glucagon Ag [Presence] in Tissue by Immune stain |
10486-9 | http://loinc.org | Hemoglobin Ag [Presence] in Tissue by Immune stain |
10487-7 | http://loinc.org | HMB-45 Ag [Presence] in Tissue by Immune stain |
10488-5 | http://loinc.org | IgA Ag [Presence] in Tissue by Immune stain |
10489-3 | http://loinc.org | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
1049-6 | http://loinc.org | H NOS Ag [Presence] on Red Blood Cells from donor |
10490-1 | http://loinc.org | IgE Ag [Presence] in Tissue by Immune stain |
10491-9 | http://loinc.org | IgG Ag [Presence] in Tissue by Immune stain |
10492-7 | http://loinc.org | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
10493-5 | http://loinc.org | IgM Ag [Presence] in Tissue by Immune stain |
10494-3 | http://loinc.org | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
10495-0 | http://loinc.org | Insulin Ag [Presence] in Tissue by Immune stain |
10496-8 | http://loinc.org | Immunoglobulin light chains.kappa Ag [Presence] in Tissue by Immune stain |
10497-6 | http://loinc.org | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
10498-4 | http://loinc.org | Keratin Ag [Presence] in Tissue by Immune stain |
10499-2 | http://loinc.org | Immunoglobulin light chains.lambda Ag [Presence] in Tissue by Immune stain |
105-7 | http://loinc.org | Ceforanide [Susceptibility] by Disk diffusion (KB) |
1050-4 | http://loinc.org | H NOS Ag [Presence] on Red Blood Cells |
10500-7 | http://loinc.org | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
10501-5 | http://loinc.org | Lutropin [Units/volume] in Serum or Plasma |
10502-3 | http://loinc.org | Lutropin Ag [Presence] in Tissue by Immune stain |
10503-1 | http://loinc.org | Lysozyme Ag [Presence] in Tissue by Immune stain |
10504-9 | http://loinc.org | Myelin basic protein Ag [Presence] in Tissue by Immune stain |
10505-6 | http://loinc.org | Myoglobin Ag [Presence] in Tissue by Immune stain |
10506-4 | http://loinc.org | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
10507-2 | http://loinc.org | Prolactin Ag [Presence] in Tissue by Immune stain |
10508-0 | http://loinc.org | Prostate specific Ag [Presence] in Tissue by Immune stain |
10509-8 | http://loinc.org | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
1051-2 | http://loinc.org | Hemolytic disease of newborn screen [interpretation] in Blood |
10510-6 | http://loinc.org | S-100 Ag Ag [Presence] in Tissue by Immune stain |
10511-4 | http://loinc.org | Serotonin Ag [Presence] in Tissue by Immune stain |
10512-2 | http://loinc.org | Somatostatin Ag [Presence] in Tissue by Immune stain |
10513-0 | http://loinc.org | Somatotropin Ag [Presence] in Tissue by Immune stain |
10514-8 | http://loinc.org | Synaptophysin Ag [Presence] in Tissue by Immune stain |
10515-5 | http://loinc.org | Thyroglobulin Ag [Presence] in Tissue by Immune stain |
10516-3 | http://loinc.org | Thyrotropin Ag [Presence] in Tissue by Immune stain |
10517-1 | http://loinc.org | Trypsin Ag [Presence] in Tissue by Immune stain |
10518-9 | http://loinc.org | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
10519-7 | http://loinc.org | Vimentin Ag [Presence] in Tissue by Immune stain |
1052-0 | http://loinc.org | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit |
10520-5 | http://loinc.org | Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
10521-3 | http://loinc.org | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
10522-1 | http://loinc.org | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
10523-9 | http://loinc.org | Fibrinogen Ag [Presence] in Tissue by Immune stain |
10524-7 | http://loinc.org | Microscopic observation [Identifier] in Cervix by Cyto stain |
10525-4 | http://loinc.org | Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
10526-2 | http://loinc.org | Microscopic observation [Identifier] in Sputum by Cyto stain |
10527-0 | http://loinc.org | Microscopic observation [Identifier] in Tissue by Cyto stain |
10528-8 | http://loinc.org | Acetophenazine [Mass/volume] in Serum or Plasma |
10529-6 | http://loinc.org | Amoxapine metabolite [Mass/volume] in Serum or Plasma |
1053-8 | http://loinc.org | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor |
10530-4 | http://loinc.org | Aprobarbital [Mass/volume] in Serum or Plasma |
10531-2 | http://loinc.org | Bretylium [Mass/volume] in Serum or Plasma |
10532-0 | http://loinc.org | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma |
10533-8 | http://loinc.org | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
10534-6 | http://loinc.org | Diazoxide [Mass/volume] in Serum or Plasma |
10535-3 | http://loinc.org | Digoxin [Mass/volume] in Serum or Plasma |
10536-1 | http://loinc.org | Dipyridamole [Mass/volume] in Serum or Plasma |
10537-9 | http://loinc.org | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |
10538-7 | http://loinc.org | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
10539-5 | http://loinc.org | Glipizide [Mass/volume] in Serum or Plasma |
1054-6 | http://loinc.org | Deprecated I (intermediate) subtype [Presence] in srum |
10540-3 | http://loinc.org | Glyburide [Mass/volume] in Serum or Plasma |
10541-1 | http://loinc.org | Mepivacaine [Mass/volume] in Serum or Plasma |
10542-9 | http://loinc.org | Metharbital [Mass/volume] in Serum or Plasma |
10543-7 | http://loinc.org | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
10544-5 | http://loinc.org | Normeperidine [Presence] in Serum or Plasma |
10545-2 | http://loinc.org | Normephenytoin [Mass/volume] in Serum or Plasma |
10546-0 | http://loinc.org | Normethsuximide [Mass/volume] in Serum or Plasma |
10547-8 | http://loinc.org | Primidone+Phenobarbital [Mass/volume] in Serum or Plasma |
10548-6 | http://loinc.org | Phenytoin Free/Phenytoin.total in Serum or Plasma |
10549-4 | http://loinc.org | Pirmenol [Mass/volume] in Serum or Plasma |
1055-3 | http://loinc.org | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
10550-2 | http://loinc.org | Deprecated Temazepam [Mass/volume] in Serum or Plasma |
10551-0 | http://loinc.org | Triamterene [Mass/volume] in Serum or Plasma |
10552-8 | http://loinc.org | Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
10553-6 | http://loinc.org | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
10554-4 | http://loinc.org | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma |
10555-1 | http://loinc.org | Acrosin [Entitic Catalytic Activity] in Spermatozoa |
10556-9 | http://loinc.org | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma |
10557-7 | http://loinc.org | Adenosine triphosphate [Moles/volume] in Semen |
10558-5 | http://loinc.org | Albumin [Moles/volume] in Semen |
10559-3 | http://loinc.org | Deprecated Calcium [Molecules/volume] in Semen |
1056-1 | http://loinc.org | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor |
10560-1 | http://loinc.org | Carcinoembryonic Ag [Units/volume] in Semen |
10561-9 | http://loinc.org | Carnitine [Moles/volume] in Semen |
10562-7 | http://loinc.org | Cells [#/volume] in Cervical mucus |
10563-5 | http://loinc.org | Cells other than spermatozoa [#/volume] in Semen |
10564-3 | http://loinc.org | Cervical mucus [Volume] |
10565-0 | http://loinc.org | Choriogonadotropin [Units/volume] in Semen |
10566-8 | http://loinc.org | Deprecated Choriogonadotropin [Molecules/volume] in Semen |
10567-6 | http://loinc.org | Citrate [Moles/volume] in Semen |
10568-4 | http://loinc.org | Clarity of Semen |
10569-2 | http://loinc.org | Color of Semen |
1057-9 | http://loinc.org | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells |
10570-0 | http://loinc.org | Consistency of Cervical mucus |
10571-8 | http://loinc.org | Consistency of Semen |
10572-6 | http://loinc.org | Deprecated Duration^post ejaculation |
10573-4 | http://loinc.org | Ferning [Type] in Cervical mucus |
10574-2 | http://loinc.org | Fructose [Moles/volume] in Semen |
10575-9 | http://loinc.org | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
10576-7 | http://loinc.org | Germ cells.immature [#/volume] in Semen |
10577-5 | http://loinc.org | Glucosidase [Enzymatic activity/volume] in Seminal plasma |
10578-3 | http://loinc.org | Glycerophosphocholine [Moles/volume] in Seminal plasma |
10579-1 | http://loinc.org | Leukocytes [#/volume] in Semen |
1058-7 | http://loinc.org | I Ab [Presence] in Serum or Plasma from Blood product unit |
10580-9 | http://loinc.org | Liquefaction [Time] in Semen |
10581-7 | http://loinc.org | Deprecated Number of entities [#] in Spermatozoa |
10582-5 | http://loinc.org | pH of Cervical mucus |
10583-3 | http://loinc.org | Prostaglandin F1 alpha [Moles/volume] in Semen |
10584-1 | http://loinc.org | Deprecated Protein [Mass/volume] in Semen |
10585-8 | http://loinc.org | Round cells [#/volume] in Semen |
10586-6 | http://loinc.org | Deprecated Volume of Semen |
10587-4 | http://loinc.org | Sexual abstinence duration |
10588-2 | http://loinc.org | Spermatogonia [#/volume] in Semen |
10589-0 | http://loinc.org | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) |
1059-5 | http://loinc.org | I Ab [Presence] in Serum or Plasma from donor |
10590-8 | http://loinc.org | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) |
10591-6 | http://loinc.org | Primary Spermatocytes [#/volume] in Semen |
10592-4 | http://loinc.org | Secondary Spermatocytes [#/volume] in Semen |
10593-2 | http://loinc.org | Spermatozoa Pyriform Head/100 spermatozoa in Semen |
10594-0 | http://loinc.org | Spermatozoa Tapering Head/100 spermatozoa in Semen |
10595-7 | http://loinc.org | Deprecated Spermatozoa [#/volume] in Semen |
10596-5 | http://loinc.org | Deprecated Spermatozoa Ab in cervical mucosa |
10597-3 | http://loinc.org | Deprecated Spermatozoa Ab in semen |
10598-1 | http://loinc.org | Deprecated Spermatozoa Ab in serum |
10599-9 | http://loinc.org | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
106-5 | http://loinc.org | Ceforanide [Susceptibility] by Serum bactericidal titer |
1060-3 | http://loinc.org | I Ab [Presence] in Serum or Plasma |
10600-5 | http://loinc.org | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
10601-3 | http://loinc.org | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
10602-1 | http://loinc.org | Spermatozoa Abnormal Head/100 spermatozoa in Semen |
10603-9 | http://loinc.org | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |
10604-7 | http://loinc.org | Spermatozoa Abnormal Tail/100 spermatozoa in Semen |
10605-4 | http://loinc.org | Spermatozoa Agglutinated/100 spermatozoa in Semen |
10606-2 | http://loinc.org | Spermatozoa Amorphous Head/100 spermatozoa in Semen |
10607-0 | http://loinc.org | Spermatozoa Coiled Tail/100 spermatozoa in Semen |
10608-8 | http://loinc.org | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen |
10609-6 | http://loinc.org | Spermatozoa Duplicate Head/100 spermatozoa in Semen |
1061-1 | http://loinc.org | I NOS Ab [Presence] in Serum or Plasma from Blood product unit |
10610-4 | http://loinc.org | Spermatozoa Duplicate Tail/100 spermatozoa in Semen |
10611-2 | http://loinc.org | Spermatozoa Immotile/100 spermatozoa in Semen |
10612-0 | http://loinc.org | Spermatozoa Large Oval Head/100 spermatozoa in Semen |
10613-8 | http://loinc.org | Spermatozoa Viable/100 spermatozoa in Semen |
10614-6 | http://loinc.org | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead |
10615-3 | http://loinc.org | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction |
10616-1 | http://loinc.org | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead |
10617-9 | http://loinc.org | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction |
10618-7 | http://loinc.org | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead |
10619-5 | http://loinc.org | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction |
1062-9 | http://loinc.org | I NOS Ab [Presence] in Serum or Plasma from donor |
10620-3 | http://loinc.org | Spermatozoa Nonprogressive/100 spermatozoa in Semen |
10621-1 | http://loinc.org | Spermatozoa Normal Head/100 spermatozoa in Semen |
10622-9 | http://loinc.org | Spermatozoa Normal/100 spermatozoa in Semen |
10623-7 | http://loinc.org | Spermatozoa Pin Head/100 spermatozoa in Semen |
10624-5 | http://loinc.org | Spermatozoa Rapid/100 spermatozoa in Semen |
10625-2 | http://loinc.org | Spermatozoa Round Head/100 spermatozoa in Semen |
10626-0 | http://loinc.org | Spermatozoa Slow/100 spermatozoa in Semen |
10627-8 | http://loinc.org | Spermatozoa Small Oval Head/100 spermatozoa in Semen |
10628-6 | http://loinc.org | Spermatozoa Tail Swelling/100 spermatozoa in Semen |
10629-4 | http://loinc.org | Spermatozoa Vacuolated Head/100 spermatozoa in Semen |
1063-7 | http://loinc.org | I NOS Ab [Presence] in Serum or Plasma |
10630-2 | http://loinc.org | Spinnbarkeit [Length] in Cervical mucus |
10631-0 | http://loinc.org | Testosterone [Moles/volume] in Semen |
10632-8 | http://loinc.org | Time until next menstrual period |
10633-6 | http://loinc.org | Zinc [Moles/volume] in Semen |
10634-4 | http://loinc.org | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
10635-1 | http://loinc.org | Acanthamoeba sp identified in Eye by Organism specific culture |
10636-9 | http://loinc.org | Acanthamoeba sp identified in Eye by Wet preparation |
10637-7 | http://loinc.org | Microscopic observation [Identifier] in Tissue by Night blue stain |
10638-5 | http://loinc.org | Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture |
10639-3 | http://loinc.org | Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture |
1064-5 | http://loinc.org | I NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10640-1 | http://loinc.org | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy |
10641-9 | http://loinc.org | Amoeba identified in Aspirate by Immune stain |
10642-7 | http://loinc.org | Amoeba identified in Aspirate by Wet preparation |
10643-5 | http://loinc.org | Amoeba identified in Stool by Organism specific culture |
10644-3 | http://loinc.org | Arthropod identified in Unspecified specimen |
10645-0 | http://loinc.org | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
10646-8 | http://loinc.org | Astrovirus [Identifier] in Stool by Electron microscopy |
10647-6 | http://loinc.org | Babesia sp identified in Blood by Thick film |
10648-4 | http://loinc.org | Babesia sp identified in Blood by Thin film |
10649-2 | http://loinc.org | Calicivirus [Identifier] in Stool by Electron microscopy |
1065-2 | http://loinc.org | I NOS Ag [Presence] on Red Blood Cells from donor |
10650-0 | http://loinc.org | Candida sp DNA [Presence] in Blood by Probe with amplification |
10651-8 | http://loinc.org | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
10652-6 | http://loinc.org | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
10653-4 | http://loinc.org | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |